Factors Leading to the Loss of Natural Elite Control of HIV-1 InfectionMaría Pernas, Ezequiel Ruíz-Mateos, Beatriz Domínguez-Molina et al.|Journal of Virology|2017Cited by 78
Safety and immunogenicity of a modified vaccinia Ankara-based HIV-1 vaccine (MVA-B) in HIV-1-infected patients alone or in combination with a drug to reactivate latent HIV-1Beatriz Mothe, Constanza Lucero, Bonaventura Clotet et al.|Journal of Antimicrobial Chemotherapy|2015Cited by 65